{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:19:06Z","timestamp":1780337946175,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10067-024-07124-x","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T09:05:12Z","timestamp":1725527112000},"page":"3515-3523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In vitro silencing of RIP2 in naive CD4+ T cells from lupus-prone mice promotes pathogenic Th17 cell differentiation"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4635-2892","authenticated-orcid":false,"given":"Zi-Cheng","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7138-778X","authenticated-orcid":false,"given":"Shu-Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2237-062X","authenticated-orcid":false,"given":"Xue-Ying","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7366-6834","authenticated-orcid":false,"given":"Jia-Jia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2453-5865","authenticated-orcid":false,"given":"Rui-Xue","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6589-1826","authenticated-orcid":false,"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"7124_CR1","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","volume":"393","author":"L Durcan","year":"2019","unstructured":"Durcan L, O\u2019Dwyer T, Petri M (2019) Management strategies and future directions for systemic lupus erythematosus in adults. Lancet 393:2332\u20132343. https:\/\/doi.org\/10.1016\/S0140-6736(19)30237-5","journal-title":"Lancet"},{"key":"7124_CR2","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365:2110\u20132121. https:\/\/doi.org\/10.1056\/NEJMra1100359","journal-title":"N Engl J Med"},{"key":"7124_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","volume":"17","author":"MRW Barber","year":"2021","unstructured":"Barber MRW, Drenkard C, Falasinnu T et al (2021) Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 17:515\u2013532. https:\/\/doi.org\/10.1038\/s41584-021-00668-1","journal-title":"Nat Rev Rheumatol"},{"key":"7124_CR4","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","volume":"384","author":"L Lisnevskaia","year":"2014","unstructured":"Lisnevskaia L, Murphy G, Isenberg D (2014) Systemic lupus erythematosus. Lancet 384:1878\u20131888. https:\/\/doi.org\/10.1016\/S0140-6736(14)60128-8","journal-title":"Lancet"},{"key":"7124_CR5","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/art.40512","volume":"70","author":"EY Yen","year":"2018","unstructured":"Yen EY, Singh RR (2018) Lupus \u2013 An Unrecognized Leading Cause of Death in Young Women: Population-based Study Using Nationwide Death Certificates, 2000\u20132015. Arthritis Rheumatol 70:1251\u20131255. https:\/\/doi.org\/10.1002\/art.40512","journal-title":"Arthritis Rheumatol"},{"key":"7124_CR6","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00296-022-05133-0","volume":"42","author":"D Nikolopoulos","year":"2022","unstructured":"Nikolopoulos D, Fotis L, Gioti O, Fanouriakis A (2022) Tailored treatment strategies and future directions in systemic lupus erythematosus. Rheumatol Int 42:1307\u20131319. https:\/\/doi.org\/10.1007\/s00296-022-05133-0","journal-title":"Rheumatol Int"},{"key":"7124_CR7","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","volume":"393","author":"L Durcan","year":"2019","unstructured":"Durcan L, O\u2019Dwyer T, Petri M (2019) Management strategies and future directions for systemic lupus erythematosus in adults. Lancet (London England) 393:2332\u20132343. https:\/\/doi.org\/10.1016\/S0140-6736(19)30237-5","journal-title":"Lancet (London England)"},{"key":"7124_CR8","doi-asserted-by":"publisher","first-page":"102870","DOI":"10.1016\/j.jaut.2022.102870","volume":"132","author":"H Li","year":"2022","unstructured":"Li H, Boulougoura A, Endo Y, Tsokos GC (2022) Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies. J Autoimmun 132:102870. https:\/\/doi.org\/10.1016\/j.jaut.2022.102870","journal-title":"J Autoimmun"},{"key":"7124_CR9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR et al (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123\u20131132. https:\/\/doi.org\/10.1038\/ni1254","journal-title":"Nat Immunol"},{"key":"7124_CR10","doi-asserted-by":"publisher","first-page":"R4","DOI":"10.1186\/ar4430","volume":"16","author":"X Yang","year":"2014","unstructured":"Yang X, Yang J, Xing X et al (2014) Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction. Arthritis Res Ther 16:R4. https:\/\/doi.org\/10.1186\/ar4430","journal-title":"Arthritis Res Ther"},{"key":"7124_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/sji.12147","volume":"79","author":"M Kostic","year":"2014","unstructured":"Kostic M, Dzopalic T, Zivanovic S et al (2014) IL-17 and glutamate excitotoxicity in the pathogenesis of multiple sclerosis. Scand J Immunol 79:181\u2013186. https:\/\/doi.org\/10.1111\/sji.12147","journal-title":"Scand J Immunol"},{"key":"7124_CR12","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/art.38343","volume":"66","author":"J Leipe","year":"2014","unstructured":"Leipe J, Schramm MA, Prots I et al (2014) Increased Th17 cell frequency and poor clinical outcome in rheumatoid arthritis are associated with a genetic variant in the IL4R gene, rs1805010. Arthritis Rheumatol 66:1165\u20131175. https:\/\/doi.org\/10.1002\/art.38343","journal-title":"Arthritis Rheumatol"},{"key":"7124_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cyto.2014.12.027","volume":"72","author":"RM Talaat","year":"2015","unstructured":"Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA (2015) Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity. Cytokine 72:146\u2013153. https:\/\/doi.org\/10.1016\/j.cyto.2014.12.027","journal-title":"Cytokine"},{"key":"7124_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/08916934.2019.1693545","volume":"53","author":"F Muhammad Yusoff","year":"2020","unstructured":"Muhammad Yusoff F, Wong KK, Mohd Redzwan N (2020) Th1, Th2, and Th17 cytokines in systemic lupus erythematosus. Autoimmunity 53:8\u201320. https:\/\/doi.org\/10.1080\/08916934.2019.1693545","journal-title":"Autoimmunity"},{"key":"7124_CR15","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/art.24499","volume":"60","author":"J Yang","year":"2009","unstructured":"Yang J, Chu Y, Yang X et al (2009) Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 60:1472\u20131483. https:\/\/doi.org\/10.1002\/art.24499","journal-title":"Arthritis Rheum"},{"key":"7124_CR16","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1177\/0961203312457718","volume":"21","author":"D-Y Chen","year":"2012","unstructured":"Chen D-Y, Chen Y-M, Wen M-C et al (2012) The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis. Lupus 21:1385\u20131396. https:\/\/doi.org\/10.1177\/0961203312457718","journal-title":"Lupus"},{"key":"7124_CR17","doi-asserted-by":"publisher","unstructured":"Wu H, Zhen Y, Ma Z, et al (2016) Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus. Sci Transl Med 8:331ra40. https:\/\/doi.org\/10.1126\/scitranslmed.aae0482","DOI":"10.1126\/scitranslmed.aae0482"},{"key":"7124_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4049\/jimmunol.1400931","volume":"193","author":"G Amarilyo","year":"2014","unstructured":"Amarilyo G, Louren\u00e7o EV, Shi F-D, La Cava A (2014) IL-17 promotes murine lupus. J Immunol 193:540\u2013543. https:\/\/doi.org\/10.4049\/jimmunol.1400931","journal-title":"J Immunol"},{"key":"7124_CR19","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.immuni.2012.08.014","volume":"37","author":"P Pisitkun","year":"2012","unstructured":"Pisitkun P, Ha H-L, Wang H et al (2012) Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity 37:1104\u20131115. https:\/\/doi.org\/10.1016\/j.immuni.2012.08.014","journal-title":"Immunity"},{"key":"7124_CR20","doi-asserted-by":"publisher","first-page":"16968","DOI":"10.1074\/jbc.273.27.16968","volume":"273","author":"JV McCarthy","year":"1998","unstructured":"McCarthy JV, Ni J, Dixit VM (1998) RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. J Biol Chem 273:16968\u201316975. https:\/\/doi.org\/10.1074\/jbc.273.27.16968","journal-title":"J Biol Chem"},{"key":"7124_CR21","doi-asserted-by":"publisher","first-page":"12296","DOI":"10.1074\/jbc.273.20.12296","volume":"273","author":"N Inohara","year":"1998","unstructured":"Inohara N, del Peso L, Koseki T et al (1998) RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J Biol Chem 273:12296\u201312300. https:\/\/doi.org\/10.1074\/jbc.273.20.12296","journal-title":"J Biol Chem"},{"key":"7124_CR22","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/s0960-9822(07)00352-1","volume":"8","author":"M Thome","year":"1998","unstructured":"Thome M, Hofmann K, Burns K et al (1998) Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr Biol 8:885\u2013888. https:\/\/doi.org\/10.1016\/s0960-9822(07)00352-1","journal-title":"Curr Biol"},{"key":"7124_CR23","doi-asserted-by":"publisher","first-page":"29651","DOI":"10.1074\/jbc.M114.591388","volume":"289","author":"JT Tigno-Aranjuez","year":"2014","unstructured":"Tigno-Aranjuez JT, Benderitter P, Rombouts F et al (2014) In vivo inhibition of RIPK2 kinase alleviates inflammatory disease. J Biol Chem 289:29651\u201329664. https:\/\/doi.org\/10.1074\/jbc.M114.591388","journal-title":"J Biol Chem"},{"key":"7124_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.immuni.2010.12.015","volume":"34","author":"PJ Shaw","year":"2011","unstructured":"Shaw PJ, Barr MJ, Lukens JR et al (2011) Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity. Immunity 34:75\u201384. https:\/\/doi.org\/10.1016\/j.immuni.2010.12.015","journal-title":"Immunity"},{"key":"7124_CR25","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.immuni.2018.08.022","volume":"49","author":"K Shimada","year":"2018","unstructured":"Shimada K, Porritt RA, Markman JL et al (2018) T-Cell-Intrinsic Receptor Interacting Protein 2 Regulates Pathogenic T Helper 17 Cell Differentiation. Immunity 49:873-885.e7. https:\/\/doi.org\/10.1016\/j.immuni.2018.08.022","journal-title":"Immunity"},{"key":"7124_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/mutage\/ger081","volume":"27","author":"J Li","year":"2012","unstructured":"Li J, Tian J, Ma Y et al (2012) Association of RIP2 gene polymorphisms and systemic lupus erythematosus in a Chinese population. Mutagenesis 27:319\u2013322. https:\/\/doi.org\/10.1093\/mutage\/ger081","journal-title":"Mutagenesis"},{"key":"7124_CR27","doi-asserted-by":"publisher","first-page":"108648","DOI":"10.1016\/j.clim.2020.108648","volume":"223","author":"SR Hofmann","year":"2021","unstructured":"Hofmann SR, Girschick L, Stein R, Schulze F (2021) Immune modulating effects of receptor interacting protein 2 (RIP2) in autoinflammation and immunity. Clin Immunol 223:108648. https:\/\/doi.org\/10.1016\/j.clim.2020.108648","journal-title":"Clin Immunol"},{"key":"7124_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/416190a","volume":"416","author":"AI Chin","year":"2002","unstructured":"Chin AI, Dempsey PW, Bruhn K et al (2002) Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416:190\u2013194. https:\/\/doi.org\/10.1038\/416190a","journal-title":"Nature"},{"key":"7124_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/416194a","volume":"416","author":"K Kobayashi","year":"2002","unstructured":"Kobayashi K, Inohara N, Hernandez LD et al (2002) RICK\/Rip2\/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416:194\u2013199. https:\/\/doi.org\/10.1038\/416194a","journal-title":"Nature"},{"key":"7124_CR30","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H Park","year":"2005","unstructured":"Park H, Li Z, Yang XO et al (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133\u20131141. https:\/\/doi.org\/10.1038\/ni1261","journal-title":"Nat Immunol"},{"key":"7124_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235\u2013238. https:\/\/doi.org\/10.1038\/nature04753","journal-title":"Nature"},{"key":"7124_CR32","doi-asserted-by":"publisher","first-page":"106187","DOI":"10.1016\/j.intimp.2020.106187","volume":"80","author":"B Wu","year":"2020","unstructured":"Wu B, Wan Y (2020) Molecular control of pathogenic Th17 cells in autoimmune diseases. Int Immunopharmacol 80:106187. https:\/\/doi.org\/10.1016\/j.intimp.2020.106187","journal-title":"Int Immunopharmacol"},{"key":"7124_CR33","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature09447","volume":"467","author":"K Ghoreschi","year":"2010","unstructured":"Ghoreschi K, Laurence A, Yang X-P et al (2010) Generation of Pathogenic Th17 Cells in the Absence of TGF-\u03b2 Signaling. Nature 467:967\u2013971. https:\/\/doi.org\/10.1038\/nature09447","journal-title":"Nature"},{"key":"7124_CR34","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature09447","volume":"467","author":"K Ghoreschi","year":"2010","unstructured":"Ghoreschi K, Laurence A, Yang X-P et al (2010) Generation of pathogenic TH17 cells in the absence of TGF-\u03b2 signalling. Nature 467:967\u2013971. https:\/\/doi.org\/10.1038\/nature09447","journal-title":"Nature"},{"key":"7124_CR35","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature09447","volume":"467","author":"K Ghoreschi","year":"2010","unstructured":"Ghoreschi K, Laurence A, Yang X-P et al (2010) Generation of pathogenic T(H)17 cells in the absence of TGF-\u03b2 signalling. Nature 467:967\u2013971. https:\/\/doi.org\/10.1038\/nature09447","journal-title":"Nature"},{"key":"7124_CR36","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni.2416","volume":"13","author":"Y Lee","year":"2012","unstructured":"Lee Y, Awasthi A, Yosef N et al (2012) Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 13:991\u2013999. https:\/\/doi.org\/10.1038\/ni.2416","journal-title":"Nat Immunol"},{"key":"7124_CR37","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1191\/096120300678828703","volume":"9","author":"CK Wong","year":"2000","unstructured":"Wong CK, Ho CY, Li EK, Lam CW (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9:589\u2013593. https:\/\/doi.org\/10.1191\/096120300678828703","journal-title":"Lupus"},{"key":"7124_CR38","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/rheumatology\/kep255","volume":"48","author":"BC-H Kwan","year":"2009","unstructured":"Kwan BC-H, Tam L-S, Lai K-B et al (2009) The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus. Rheumatology (Oxford) 48:1491\u20131497. https:\/\/doi.org\/10.1093\/rheumatology\/kep255","journal-title":"Rheumatology (Oxford)"},{"key":"7124_CR39","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.bbrc.2017.07.035","volume":"493","author":"C-H Zhao","year":"2017","unstructured":"Zhao C-H, Ma X, Guo H-Y et al (2017) RIP2 deficiency attenuates cardiac hypertrophy, inflammation and fibrosis in pressure overload induced mice. Biochem Biophys Res Commun 493:1151\u20131158. https:\/\/doi.org\/10.1016\/j.bbrc.2017.07.035","journal-title":"Biochem Biophys Res Commun"},{"key":"7124_CR40","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","volume":"30","author":"Y Chung","year":"2009","unstructured":"Chung Y, Chang SH, Martinez GJ et al (2009) Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling. Immunity 30:576\u2013587. https:\/\/doi.org\/10.1016\/j.immuni.2009.02.007","journal-title":"Immunity"},{"key":"7124_CR41","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/s41374-019-0252-7","volume":"99","author":"S Li","year":"2019","unstructured":"Li S, Deng P, Wang M et al (2019) IL-1\u03b1 and IL-1\u03b2 promote NOD2-induced immune responses by enhancing MAPK signaling. Lab Invest 99:1321\u20131334. https:\/\/doi.org\/10.1038\/s41374-019-0252-7","journal-title":"Lab Invest"},{"key":"7124_CR42","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.4049\/jimmunol.1202416","volume":"191","author":"FY Goh","year":"2013","unstructured":"Goh FY, Cook KLTP, Upton N et al (2013) Receptor-Interacting Protein 2 Gene Silencing Attenuates Allergic Airway Inflammation. J Immunol 191:2691\u20132699. https:\/\/doi.org\/10.4049\/jimmunol.1202416","journal-title":"J Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07124-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07124-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07124-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T09:04:38Z","timestamp":1729242278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07124-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["7124"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07124-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"15 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}